Nonspecific Endonuclease Market Growth Driven by Clinical Trials and CRISPR-Cas9 Innovations in 2025
According to market projections, the nonspecific endonuclease market size to capture US$ 424.58 mn in 2025 and is to soar US$ 641.37 mn by 2030. The nonspecific endonuclease market is growing, driven by demand in gene therapy and genetic engineering, especially in North America and Asia Pacific. Used for DNA/RNA cleavage in research and therapy, these enzymes hold potential in treating genetic disorders and cancer. However, high production costs and product unreliability present challenges.
Last Updated : 21 April 2026
Category: Biotechnology
Insight Code: 5271
Format: PDF / PPT / Excel